VaramirStart free · no cardSign in
XNCR as of Oct 31 · 07:58 ET
XNCRNasdaqPharmaceutical Preparations

Xencor Inc · Brief

Next report

68 days

Jan 7 · before openest.
Earnings

Expected move

No implied move.

Implied vs realized

8 reportsHistory
0 of 8≥ implied
avg implied
±25.3%
avg realized
±6.9%
Aug 6 '25±43.9%▼−2.27%×0.05
Q3 FY25±24.5%▼−2.57%×0.11
Jan 8 '26±26.0%▼−5.08%×0.20
Q1 FY26±34.7%▲+13.11%×0.38
May 6 '26±12.0%▼−5.38%×0.45
Q2 FY26±22.8%▲+10.04%×0.44
Aug 5 '26±12.8%▲+0.81%×0.06
Oct 26 '26±26.0%▲+15.89%×0.61
quarterimplied−45%0+45%realized×
Oct '26±26.0%▲+15.89%×0.61
Aug '26±12.8%▲+0.81%×0.06
Q2 FY26±22.8%▲+10.04%×0.44
May '26±12.0%▼−5.38%×0.45
Q1 FY26±34.7%▲+13.11%×0.38
Jan '26±26.0%▼−5.08%×0.20
2 older reports
Q3 FY25±24.5%▼−2.57%×0.11
Aug '25±43.9%▼−2.27%×0.05
Shaded = implied · tick ▲▼ = realized · × = |realized| ÷ impliedSource: options EOD · implied at prior close · realized close to close

Bull & bear

Jan 7 report · est.

—

Linked exposure

XNCR report session

Customers 2

ZBIOZenas BioPharma×0.59VIRVir Bio×0.45
× = co-movement · max 501dSource: SEC filings · market data

Latest changes

30 daysAll changes
Oct 23impliedImplied move: ±26.0% into Oct 26 earnings (Oct 23 close).Source
Oct 21impliedImplied move: ±27.2% into Nov 4 earnings (Oct 21 close).Source

Your note

privateThesis 0 · Decisions 0 · Observations 0

No thesis.